| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/19/2006 | WO2006072803A3 Antibody |
| 10/19/2006 | WO2006066078A3 Fcϝriib-specific antibodies and methods of use thereof |
| 10/19/2006 | WO2006065975B1 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 10/19/2006 | WO2006050964A3 Indinavir derivatives useful in immunoassay |
| 10/19/2006 | WO2006030220A9 Compositions monovalent for cd40l binding and methods of use |
| 10/19/2006 | WO2006023791A3 Methods and compositions for treating allergic inflammation |
| 10/19/2006 | WO2006008294A3 Diagnostic and therapeutic use of slim3 for neurodegenerative diseases |
| 10/19/2006 | WO2005081783A3 Method for determination and quantification of radiation or genotoxin exposure |
| 10/19/2006 | WO2005016132A3 Diagnostics for sars virus |
| 10/19/2006 | WO2004084810A3 Novel imidazoline receptor homologs |
| 10/19/2006 | US20060236433 Nicotiana hybrids and plant varieties for use in production of pharmaceuticals |
| 10/19/2006 | US20060236428 Manipulation of cellulose and/or beta-1,4-glucan |
| 10/19/2006 | US20060236418 Genetically modified non-human mammals and cells |
| 10/19/2006 | US20060236417 Germinal center-associated nuclear protein (GANP); high affinity antibody; humanizing |
| 10/19/2006 | US20060236411 Antagonists il-15 |
| 10/19/2006 | US20060236410 Protein specific for cardiac and skeletal muscle |
| 10/19/2006 | US20060235209 Use of anti-tissue factor antibodies for treating thromboses |
| 10/19/2006 | US20060235208 Immunoglobulin with enhanced affinity for Fc gamma R; immunotherapy; tissue targeted therapy; directed protein evolution; antibody dependent cell-mediated cytotoxicity |
| 10/19/2006 | US20060235207 Antibodies against lesion tissue |
| 10/19/2006 | US20060235206 Monoclonal antibodies that bind Pseudomona mucoid heteropolysaccharides; used in the diagnosis, prophylaxis and therapy of P. aeruginosa infection and related disorders (e.g., cystic fibrosis); enhance opsonophagocytic killing of multiple mucoid strains |
| 10/19/2006 | US20060235203 MN gene and protein |
| 10/19/2006 | US20060235201 Enduring T cell response |
| 10/19/2006 | US20060234968 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 10/19/2006 | US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis |
| 10/19/2006 | US20060234917 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 10/19/2006 | US20060234344 Protein kinases |
| 10/19/2006 | US20060234342 Human DNA topoisomerase I alpha |
| 10/19/2006 | US20060234340 Human heavy chain antibody expression in flamentous fungi |
| 10/19/2006 | US20060234318 agent for detecting a cancer, which comprises a monoclonal antibody that specifically binds to a Mina 53 peptide; produced by hybridoma FERM BP-10157 |
| 10/19/2006 | US20060234317 Method of screening |
| 10/19/2006 | US20060234311 Isolating cells expressing secreted proteins |
| 10/19/2006 | US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2) |
| 10/19/2006 | US20060234286 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 10/19/2006 | US20060234280 Enyzmes having alpha amylase activity and methods of making and using them |
| 10/19/2006 | US20060234260 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 10/19/2006 | US20060234255 Novel proteins and nucleic acids encoding same |
| 10/19/2006 | US20060234246 diagnosing cancer; drug screening; inhibiting growth of a tumor cell by modulating expression of a gene product |
| 10/19/2006 | US20060234232 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 10/19/2006 | US20060234226 Non-affinity purification of proteins |
| 10/19/2006 | US20060234220 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 10/19/2006 | US20060234214 Methods of detecting hepatitis C virus |
| 10/19/2006 | US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses |
| 10/19/2006 | US20060234211 Arterivirus (RNA enveloped virus); polypeptides with sensitivity and specificity; decreasing the incidence of false positives in a diagnostic assay |
| 10/19/2006 | US20060233827 85kDa neisserial antigen |
| 10/19/2006 | US20060233826 Nucleotide sequences coding chlamydial membrane protein for use in generating neutralizing antibody which prevents micoorganismal infection |
| 10/19/2006 | US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 10/19/2006 | US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 10/19/2006 | US20060233820 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection |
| 10/19/2006 | US20060233818 Organic compounds |
| 10/19/2006 | US20060233817 Peptide-based immunization therapy for treatment of atherosclerosis |
| 10/19/2006 | US20060233814 Elimination of heterogeneous or mixed cell population in tumors |
| 10/19/2006 | US20060233812 Focussed antibody technology |
| 10/19/2006 | US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 10/19/2006 | US20060233808 Peptabody for cancer treatment |
| 10/19/2006 | US20060233805 Antigen uptake receptor for candida albicans on dendritic cells |
| 10/19/2006 | US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis |
| 10/19/2006 | US20060233802 Tumour necrosis factor binding ligands |
| 10/19/2006 | US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 10/19/2006 | US20060233800 Biological products |
| 10/19/2006 | US20060233799 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases |
| 10/19/2006 | US20060233798 Methods for inhibiting HIV-1 infection |
| 10/19/2006 | US20060233796 Method of modulating memory effector T-cells and compositions |
| 10/19/2006 | US20060233794 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 10/19/2006 | US20060233793 Use of anti-cd100 antibodies |
| 10/19/2006 | US20060233792 novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents |
| 10/19/2006 | US20060233790 Immunoglobulin/hydrophilic peptide complexes |
| 10/19/2006 | US20060233789 Process for producing antigenic substance |
| 10/19/2006 | US20060233788 Anti-ghrelin antibodies |
| 10/19/2006 | US20060233787 Human cd3-specific antibody with immunosuppressive properties |
| 10/19/2006 | US20060233785 Immunointeractive molecules and uses thereof |
| 10/19/2006 | US20060233758 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 10/19/2006 | US20060233710 Prevention and treatment for GVHD |
| 10/19/2006 | CA2604443A1 Use of anti-ngf antibody for improving stiffness in osteoarthritis |
| 10/19/2006 | CA2604423A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor |
| 10/19/2006 | CA2604300A1 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues |
| 10/19/2006 | CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use |
| 10/19/2006 | CA2604036A1 Cathepsin s antibody |
| 10/19/2006 | CA2603847A1 Conjugated anti-psma antibodies |
| 10/19/2006 | CA2603264A1 Antibody substituting for function of blood coagulation factor viii |
| 10/19/2006 | CA2600709A1 Use of cd25 antibodies in immunotherapy |
| 10/19/2006 | CA2595276A1 Anti-interferon gamma antibodies and methods of use thereof |
| 10/18/2006 | EP1712636A1 Method of quickly measuring factor causing early flocculation of yeast |
| 10/18/2006 | EP1712631A2 Fc receptors and polypeptides |
| 10/18/2006 | EP1712629A2 Compounds and methods for diagnosis of tuberculosis |
| 10/18/2006 | EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 10/18/2006 | EP1712626A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 10/18/2006 | EP1712620A1 Peptide originating in epidermal growth factor receptor (egfr) |
| 10/18/2006 | EP1712619A1 Preventive/remedy for cancer |
| 10/18/2006 | EP1712566A1 Inflammatory cytokine inhibitor |
| 10/18/2006 | EP1712565A1 Cell death inducing agents |
| 10/18/2006 | EP1712564A1 Anti-nc1 monoclonal antibody |
| 10/18/2006 | EP1712563A1 Method of isolating monocytes |
| 10/18/2006 | EP1711834A2 Process for screening glycoform-specific antibodies |
| 10/18/2006 | EP1711615A2 Engineered templates and their use in single primer amplification |
| 10/18/2006 | EP1711610A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 10/18/2006 | EP1711604A1 Diabetogenic epitopes |
| 10/18/2006 | EP1711531A2 Neutralizing antibodies and methods of use thereof |
| 10/18/2006 | EP1711530A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 10/18/2006 | EP1711529A1 Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell |
| 10/18/2006 | EP1711528A2 Treatment of cancer with novel anti-il 13 monoclonal antibodies |